[go: up one dir, main page]

USPP36496P3 - Cannabis plant named ‘ow-1’ - Google Patents

Cannabis plant named ‘ow-1’ Download PDF

Info

Publication number
USPP36496P3
USPP36496P3 US18/445,004 US202318445004V USPP36496P3 US PP36496 P3 USPP36496 P3 US PP36496P3 US 202318445004 V US202318445004 V US 202318445004V US PP36496 P3 USPP36496 P3 US PP36496P3
Authority
US
United States
Prior art keywords
variety
color
plant
cannabis
plants
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
US18/445,004
Other versions
US20230337560P1 (en
Inventor
David Straub
Matt Gore
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US18/445,004 priority Critical patent/USPP36496P3/en
Publication of US20230337560P1 publication Critical patent/US20230337560P1/en
Application granted granted Critical
Publication of USPP36496P3 publication Critical patent/USPP36496P3/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01H—NEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
    • A01H6/00—Angiosperms, i.e. flowering plants, characterised by their botanic taxonomy
    • A01H6/28—Cannabaceae, e.g. cannabis

Definitions

  • Genus Cannabis.
  • Species sativa.
  • the present invention relates to a new and distinct annual variety of C. sativa hybrid, which has been given the variety denomination of ‘OW-1’.
  • ‘OW-1’ is intended for use as medicinal herb, for sale in Cannabis dispensaries, and as a home garden plant.
  • the genus Cannabis has been in use by humans for millennia, due to the multiplicity of its benefits to humans, including the considerable value and utility of its fiber, the nutritional value of its seeds, and the medicinal value of its floral parts and products made from them.
  • the genus is under intense legal commercialization in the United States as industrial hemp for a variety of purposes including biodegradable plastics and building materials, clothing, paper, food, fuel and medicines.
  • Cannabidiol (CBD) extracted from Cannabis is widely used in over-the-counter medicines and topical treatments and is also the active ingredient in the FDA-approved drug Epidiolex® (cannabidiol).
  • CBD is just one of at least dozens—perhaps hundreds—of cannabinoids endogenous to Cannabis , tetrahydrocannabinol (THC) being the other cannabinoid that is most well-known.
  • THC tetrahydrocannabinol
  • the cannabinoids as a group interact with the human endocannabinoid receptors, which are distributed in the brain and throughout the body.
  • ECS endocannabinoid system
  • Non-hemp forms of Cannabis frequently referred to as marijuana, have been legalized for medicinal use in many states and also for recreational use (sometimes called “adult use”) in a growing number of states including Alaska, Arizona, California, Colorado, Illinois, Maine, Massachusetts, Michigan, Montana, New Jersey, Nevada, Oregon, Vermont, and Washington. It is expected that the wave of legalization will continue to the point of some form of federal legalization or decriminalization.
  • marijuana products are available to users for purchase in specialized “dispensaries” that offer dried flower, edibles, tinctures, extracts, and the like.
  • a unique or unusual chemical profile, or chemotype is attractive not only for flower sales but also for use in the preparation of extracts and/or isolates and for the manufacture of a variety of products that possess characteristics of the chemotype.
  • C. sativa cultivar ‘OW-1’ is a new cultivar which has elevated levels of CBGA.
  • C. sativa cultivar ‘OW-1’ is a tall growing plant. The variety has a strong fragrance at 7 weeks old. The variety has a very low flower to leaf ratio of 6 to 1. The variety grows best with warm days, cool nights, and high nutrient base feeding.
  • the variety can be used to treat certain medical conditions.
  • the variety can be used to treat rheumatoid arthritis.
  • the variety can be used to treat bowel disorders such as Crohn's Disease.
  • the new variety is a result of controlled cross of wild Oaxacan (unpatented) and ‘Pennywise’ (unpatented) in Willow, Alaska, performed in 2012.
  • the new variety differs from the parental wild Oaxacan variety primarily in terms of its terpene profile, such that the new variety has a markedly more floral aroma than the wild Oaxacan variety, whose aroma is characterized by carthy herbs, peppery fruits, and a sour citrus overtone.
  • the new variety differs from the parental ‘Pennywise’ variety in that it contains a greater percentage of THC, CBGA, and terpenes, and a lower percentage of CBD, as compared with ‘Pennywise’.
  • the closest comparison variety is the parental ‘Pennywise’ variety.
  • Methods of growing the variety include the use of soil comprising high calcium magnesium.
  • the soil can have a pH of 6.0-6.5.
  • ‘OW-1’ can have a cannabinoid profile as set forth in Table 1 and a terpene profile as set forth in Table 2.
  • Chemotypic characteristics of each new variety are variable based upon cultivation conditions, as is typical of Cannabis plants. Accordingly, while chemotypic information provided herein is representative of performance of the new varieties under a particular set of cultivation conditions, it is not limiting on other chemotypic profiles obtainable under a different set of cultivation conditions.
  • Table 1 and Table 2 provides exemplary profiles as determined by a testing laboratory using methods such as high-performance liquid chromatography (HPLC) and gas chromatography with mass spectrometry. Such tests were performed on harvested material of the new variety after indoor cultivation in Willow, Alaska, where cultivation temperature varied between 56 and 80 degrees F.
  • HPLC high-performance liquid chromatography
  • FIG. 1 depicts an inflorescence of ‘OW-1’ at 7 weeks after induction of flowering, at a total age of 19 weeks after cloning.
  • FIG. 2 depicts an inflorescence of ‘OW-1’ at 7 weeks after induction of flowering, at a total age of 19 weeks after cloning.
  • FIG. 3 depicts the leaves of ‘OW-1’ at 8 weeks of growth under vegetative conditions.
  • FIG. 4 depicts inflorescence of ‘OW-1’ at 7 weeks after induction of flowering, at a total age of 19 weeks after cloning.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Physiology (AREA)
  • Botany (AREA)
  • Developmental Biology & Embryology (AREA)
  • Environmental Sciences (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

The unique Cannabis plant C. sativa ‘OW-1’ is provided. The variety can be distinguished by its elevated levels of CBGA.

Description

Latin name of the genus and species: Genus—Cannabis. Species—sativa.
Variety denomination: The new Cannabis plant claimed is of the variety denominated ‘OW-1’.
BACKGROUND OF THE INVENTION Field of the Invention
The present invention relates to a new and distinct annual variety of C. sativa hybrid, which has been given the variety denomination of ‘OW-1’. ‘OW-1’ is intended for use as medicinal herb, for sale in Cannabis dispensaries, and as a home garden plant.
Background of the Related Art
The genus Cannabis has been in use by humans for millennia, due to the multiplicity of its benefits to humans, including the considerable value and utility of its fiber, the nutritional value of its seeds, and the medicinal value of its floral parts and products made from them. Currently the genus is under intense legal commercialization in the United States as industrial hemp for a variety of purposes including biodegradable plastics and building materials, clothing, paper, food, fuel and medicines.
Cannabidiol (CBD) extracted from Cannabis is widely used in over-the-counter medicines and topical treatments and is also the active ingredient in the FDA-approved drug Epidiolex® (cannabidiol). CBD is just one of at least dozens—perhaps hundreds—of cannabinoids endogenous to Cannabis, tetrahydrocannabinol (THC) being the other cannabinoid that is most well-known. The cannabinoids as a group interact with the human endocannabinoid receptors, which are distributed in the brain and throughout the body. The study of the endocannabinoid system (ECS) in humans and other mammals is an area of increasing interest and holds tremendous promise for the future of medicine. See, e.g., Russo (2019). Cannabis and Pain, Pain Medicine, 20(10): 1093/pm/pnz227; and Russo (2016). Clinical Endocannabinoid Deficiency Reconsidered: Current Research Supports the Theory in Migraine, Fibromyalgia, Irritable Bowel, and Other Treatment-Resistant Syndromes, Cannabis Cannabinoid Res. 1(1): 154-165.
Non-hemp forms of Cannabis, frequently referred to as marijuana, have been legalized for medicinal use in many states and also for recreational use (sometimes called “adult use”) in a growing number of states including Alaska, Arizona, California, Colorado, Illinois, Maine, Massachusetts, Michigan, Montana, New Jersey, Nevada, Oregon, Vermont, and Washington. It is expected that the wave of legalization will continue to the point of some form of federal legalization or decriminalization.
Typically, marijuana products are available to users for purchase in specialized “dispensaries” that offer dried flower, edibles, tinctures, extracts, and the like. In some cases, a unique or unusual chemical profile, or chemotype, is attractive not only for flower sales but also for use in the preparation of extracts and/or isolates and for the manufacture of a variety of products that possess characteristics of the chemotype.
SUMMARY OF THE INVENTION
C. sativa cultivar ‘OW-1’ is a new cultivar which has elevated levels of CBGA. C. sativa cultivar ‘OW-1’ is a tall growing plant. The variety has a strong fragrance at 7 weeks old. The variety has a very low flower to leaf ratio of 6 to 1. The variety grows best with warm days, cool nights, and high nutrient base feeding.
The variety can be used to treat certain medical conditions. For example, the variety can be used to treat rheumatoid arthritis. For example, the variety can be used to treat bowel disorders such as Crohn's Disease.
The new variety is a result of controlled cross of wild Oaxacan (unpatented) and ‘Pennywise’ (unpatented) in Willow, Alaska, performed in 2012. The new variety differs from the parental wild Oaxacan variety primarily in terms of its terpene profile, such that the new variety has a markedly more floral aroma than the wild Oaxacan variety, whose aroma is characterized by carthy herbs, peppery fruits, and a sour citrus overtone. The new variety differs from the parental ‘Pennywise’ variety in that it contains a greater percentage of THC, CBGA, and terpenes, and a lower percentage of CBD, as compared with ‘Pennywise’. The closest comparison variety is the parental ‘Pennywise’ variety.
Methods of growing the variety include the use of soil comprising high calcium magnesium. The soil can have a pH of 6.0-6.5.
The variety has been asexually reproduced by vegetative propagation (cloning) from mother plants in Willow, Alaska, beginning in 2013. Asexual reproduction of the new variety has demonstrated that the new variety reproduces true to type with all of the morphological characteristics, as herein described, firmly fixed and retained through successive generations of such asexual propagation.
‘OW-1’ can have a cannabinoid profile as set forth in Table 1 and a terpene profile as set forth in Table 2. Chemotypic characteristics of each new variety are variable based upon cultivation conditions, as is typical of Cannabis plants. Accordingly, while chemotypic information provided herein is representative of performance of the new varieties under a particular set of cultivation conditions, it is not limiting on other chemotypic profiles obtainable under a different set of cultivation conditions. Table 1 and Table 2 provides exemplary profiles as determined by a testing laboratory using methods such as high-performance liquid chromatography (HPLC) and gas chromatography with mass spectrometry. Such tests were performed on harvested material of the new variety after indoor cultivation in Willow, Alaska, where cultivation temperature varied between 56 and 80 degrees F. Due to the natural variability of chemotypic expression that is commonly observed in Cannabis plants, arising from numerous causes such as cultivation conditions, the values set forth in the tables do not reflect the only possible range of outcomes that can be obtained from plants of the new variety. Thus, these values are merely exemplary of observed values (middle column) and predicted normal variations from the observed values.
TABLE 1
Exemplary Profiles of Key Cannabinoids.
Percent** Percent Percent Percent Percent
THCA 12.54 16.90 21.80 26.16 30.52
THC 0.02 0.18 0.79 1.83 1.99
Total THC* 12.24 16.23 19.95 23.70 27.69
THCVA 0.00 0.27 0.05 0.23 0.24
CBGA 0.00 1.90 4.20 6.15 6.99
CBG 0.07 0.17 0.52 0.71 0.81
Total CBD 0.03 0.04 0.06 0.07 0.08
Total 15.18 20.67 27.47 32.22 37.71
Cannabinoid
*Total THC = (THCA * 0.877) + THC (i.e. delta 9 THC) + delta 8 THC
**Percent = Percent (dry weight of flower)
TABLE 2
Exemplary Profiles of Key Terpenes.
Percent Percent Percent Percent Percent
Alpha Pinene 0.04 0.06 0.11 0.31 0.33
P Cymene 0.00 0.01 0.01 0.09 0.09
G-Terpinene 0.01 0.02 0.03 0.04 0.05
A-Humulene 0.00 0.02 0.13 0.25 0.28
A-Bisabolol 0.00 0.01 0.01 0.02 0.02
Beta Pinene 0.07 0.09 0.13 0.18 0.21
D3carene 0.03 0.04 0.07 0.10 0.11
Limonene 0.11 0.14 0.17 0.25 0.28
Terpinolene 0.00 0.32 0.64 1.08 1.21
Neroliodol 0.00 0.01 0.03 0.04 0.05
Beta Myrcene 0.21 0.30 0.47 0.80 0.89
A-Terpinene 0.00 0.01 0.02 0.05 0.05
Ocimene 0.27 0.39 0.60 1.05 1.17
Linalool 0.01 0.01 0.02 0.06 0.06
B-Caryophyllene 0.06 0.14 0.38 0.68 0.76
Terpene Total 0.96 1.56 3.01 4.80 5.40
**Percent = Percent (dry weight of flower)
BRIEF DESCRIPTION OF PICTURES
The accompanying photographs show the typical appearance of the new variety ‘OW-1’. The colors are as nearly true as is reasonably possible in a color representation of this type. Colors in the photographs may differ slightly from the color values cited in the detailed botanical description which accurately describes the colors of the new plant. All color specifications provided herein are based upon the RBG Color Model, which uses numerical representations for color, with three “coordinates” that indicate a value for Red, Blue, and Green, in that order. Color quantification was achieved, where feasible, with a digital color sensor colorimeter. Where use of such colorimeter was not feasible do to exceedingly small size of certain structures, such structures were matched with like color samples, which were then read digitally.
FIG. 1 depicts an inflorescence of ‘OW-1’ at 7 weeks after induction of flowering, at a total age of 19 weeks after cloning.
FIG. 2 depicts an inflorescence of ‘OW-1’ at 7 weeks after induction of flowering, at a total age of 19 weeks after cloning.
FIG. 3 depicts the leaves of ‘OW-1’ at 8 weeks of growth under vegetative conditions.
FIG. 4 depicts inflorescence of ‘OW-1’ at 7 weeks after induction of flowering, at a total age of 19 weeks after cloning.
 DETAILED BOTANICAL DESCRIPTION
The following detailed description sets forth the distinctive characteristics of ‘OW-1’. The data which define these characteristics were collected from asexual reproductions of the original selection, on plants that were 7 weeks into the flowering stage. Induction of flowering occurs in plants that are in vegetative growth, either by natural changes in daylength or by induction of flowering through changes in lighting of the plants. Ages provided herein are counted from the beginning of the induction of flowering and are typically reported in weeks. Because the duration of vegetative growth can be variable and can be based upon desired plant size, absolute age of plants is less relevant and can be, itself, quite variable. Dimensions, sizes, colors, and other characteristics are approximations and averages set forth as accurately as possible.
  • Type: Herbaceous tap-rooted annual.
      • a. Family.—Cannabaceae.
      • b. Genus.—Cannabis.
      • c. Species.—sativa.
      • d. Common name.—Marijuana.
  • Market class: A medicinal herb intended for use as medical oil, and medicinal herb for sale in Cannabis dispensaries and as a home garden plant.
PLANT
  • General:
      • a. Parentage.—Oaxacan (unpatented) x Pennywise (unpatented).
      • b. Growth habit.—Bushy.
      • c. Height.—6-7 ft.
      • d. Spread.—3 ft.
      • e. Growth rate.—Upon transition from vegetative growth to flowering, plant “stretches” approximately 3× in height and length of main branches.
      • f. Cold tolerance.—50-55° F.
      • g. Proportion of hermaphrodite plants.—Low, none seen in 7 years.
      • h. Proportion of female plants.—100%.
      • i. Proportion of male plants.—0%.
BRANCHES
  • General:
      • a. Branching habit.—Sporadic at angles (30°).
      • b. Primary branch number.—3 to 6.
      • c. Length.—3 ft.
      • d. Diameter.—½ in.
      • e. Texture.—Rough.
      • f. Strength.—Strong.
      • g. Internode length.—Depends on position in the plant; internodes are longer near the top of the plant; near the bottom of the plant, internodes are about 4 mm; closer to the top of the plant, internodes are about 17-24 mm.
      • h. Color.—Ranges from Green (#849249: 132,146,73) to Violet (#53455B: 83,69,91).
STEMS
  • General:
      • a. Length.—6 in.
      • b. Diameter.—¼ in.
      • c. Texture.—Rough.
      • d. Color.—Ranges from Green (#849249: 132,146,73) to Violet (#53455B: 83,69,91).
LEAVES
  • General:
      • a. Leaf arrangement.—1 per flower spot.
      • b. Leaf type.—Large, long tapered leaves.
      • c. Number per plant.—40 to 50.
      • d. Length.—4 in.
      • e. Width.—2½ in.
  • Leaflets:
      • a. Number.—Typically 5.
      • b. Length.—Depends on age of leaf; outer leaflets are shorter, central leaflet is longest, up to about 13 cm.
      • c. Width.—Central leaflet typically 1.2-1.5 cm in width.
      • d. Shape.—Typical of Cannabis leaflets.
      • e. Apex.—Accuminate.
      • f. Margin.—Serrate.
      • g. Base.—Acute.
      • h. Texture of upper surface.—Smooth.
      • i. Texture of lower surface.—Rough.
      • j. Color of upper surface.—#4D6221 — Hue: green.
      • k. Color of lower surface.—#667D3A — Hue: green.
      • l. Venation pattern.—Palmate.
      • m. Venation color is similar to color of other parts of upper and lower surface of leaflet. Venation is more notable by structural differences than by color differences.
PETIOLE
  • General:
      • a. Length.—Highly variable depending upon age of plant and position of leaf on plant. Average length of petiole at mid-point of mature plant in flowering stage is approximately 4 inches.
      • b. Width.—Highly variable depending upon age of plant and position of leaf on plant. Average width of petiole at mid-point of mature plant in flowering stage is approximately 5 mm.
      • c. Texture.—Smooth.
      • d. Color.—Ranges from Green (#849249: 132,146,73) to Medium Purple (9370DB: 147,112,219).
FLOWER
  • Inflorescence:
      • a. Shape.—Elongated at upper portions of plant, oval to round on lower and lateral inflorescences.
      • b. Length.—2½ in to 4 in.
      • c. Diameter.—1½ in to 2½ in.
      • d. Texture.—Firm and sticky.
      • e. Color.—Ranges from Golden Foil (#c3c300: 195,195,0) to Green (#769241: 118,146,65).
      • f. Fragrance.—Intensely floral, characteristic of high amounts of terpinolene and ocimene.
      • g. Natural flowering season.—Depends upon latitude and can be affected by elevation; for outdoor-grown plants, flowering generally begins in August.
  • Bracts (“sugar leaves” of inflorescence):
      • a. Number.—10 to 20.
      • b. Shape.—Similar in shape to vegetative leaflets.
      • c. Length.—Variable, up to 3 inches.
      • d. Width.—⅓ in.
      • e. Apex.—Accuminate.
      • f. Margin.—Serrate.
      • g. Base.—Acute.
      • h. Texture of upper surface.—Rough — lightly to densely covered in trichomes.
      • i. Texture of lower surface.—Rough — lightly to densely covered in trichomes.
      • j. Color of upper surface.—#4D6221 — Hue: green.
      • k. Color of lower surface.—#667D3A — Hue: green.
      • l. Venation pattern.—Palmate.
      • m. Venation color is similar to color of other parts of upper and lower surface of leaflet. Venation is more notable by structural differences than by color differences.
  • Stigma:
      • a. Number.—6 to 8 per flower.
      • b. Shape.—Round.
      • c. Length.—⅛ in.
      • d. Color.—Creamy white (#f0e9d6: 240,233,214) to amber (#ffbf00: 255,191,0).
  • Seeds: None observed.

Claims (1)

The invention claimed is:
1. A new and distinct variety of Cannabis plant named ‘OW-1’, as illustrated and described herein.
US18/445,004 2019-12-12 2023-02-27 Cannabis plant named ‘ow-1’ Active USPP36496P3 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US18/445,004 USPP36496P3 (en) 2019-12-12 2023-02-27 Cannabis plant named ‘ow-1’

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962947519P 2019-12-12 2019-12-12
US202017119082 2020-12-11
US18/445,004 USPP36496P3 (en) 2019-12-12 2023-02-27 Cannabis plant named ‘ow-1’

Publications (2)

Publication Number Publication Date
US20230337560P1 US20230337560P1 (en) 2023-10-19
USPP36496P3 true USPP36496P3 (en) 2025-02-25

Family

ID=88307098

Family Applications (1)

Application Number Title Priority Date Filing Date
US18/445,004 Active USPP36496P3 (en) 2019-12-12 2023-02-27 Cannabis plant named ‘ow-1’

Country Status (1)

Country Link
US (1) USPP36496P3 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USPP35171P2 (en) * 2021-11-17 2023-05-16 MH Consulting, LLC Cannabis plant named ‘SW0’
USPP35380P3 (en) * 2021-12-09 2023-09-12 Vertanical GmbH Cannabis plant named ‘DKJ127’

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USPP35171P2 (en) * 2021-11-17 2023-05-16 MH Consulting, LLC Cannabis plant named ‘SW0’
USPP35380P3 (en) * 2021-12-09 2023-09-12 Vertanical GmbH Cannabis plant named ‘DKJ127’

Also Published As

Publication number Publication date
US20230337560P1 (en) 2023-10-19

Similar Documents

Publication Publication Date Title
USPP32473P3 (en) Cannabis plant named ‘BIHEMP 050924’
Brandão et al. Nutritional value of the pulp of different sugar apple cultivars (Annona squamosa L.)
US20200323164A1 (en) Cannabis plant named 'v3'
US20200323162A1 (en) Cannabis plant named 'v1'
Singh et al. Karonda
USPP36496P3 (en) Cannabis plant named ‘ow-1’
USPP35171P2 (en) Cannabis plant named ‘SW0’
USPP33332P3 (en) Cannabis plant named ‘HAPPY PINEAPPLE’
US20220159921A1 (en) Cannabis plant named 'drg3'
US20220007610A1 (en) Cannabis plant named 'drg1'
USPP36307P3 (en) Cannabis plant named ‘21AF0716’
USPP33162P3 (en) Hemp plant named ‘Eighty Eight’
USPP35836P3 (en) Cannabis plant named ‘OT-1’
US20230329130P1 (en) Cannabis Plant Named 'DRG2'
US20220256799A1 (en) Cannabis plant named 'lpa004'
USPP34829P3 (en) Cannabis plant named BAGZXCD6-PA#2
US20230337561P1 (en) Cannabis plant named 'drg1'
US20240306521P1 (en) Cannabis plant named 'rsbt1brm'
US20230301221P1 (en) Cannabis plant named 'DRG3'
US20220330466P1 (en) Cannabis plant named 'vb252x'
Othman et al. Preliminary morphological and phytochemical evaluation of Momordica cochinchinensis Spreng
US20220007611A1 (en) Cannabis plant named 'drg2'
US20210219511A1 (en) Cannabis plant named 'OW-1'
Sedláčková et al. Morphological characteristics of selected flower parts of Cucurbita pepo L. Styriaca Group
Coker Edibles for the Landscape©

Legal Events

Date Code Title Description
FEPP Fee payment procedure

Free format text: ENTITY STATUS SET TO UNDISCOUNTED (ORIGINAL EVENT CODE: BIG.); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY

FEPP Fee payment procedure

Free format text: ENTITY STATUS SET TO SMALL (ORIGINAL EVENT CODE: SMAL); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY